Products

What will AGI do for Aldesleukin?

This classification denotes a therapeutic interleukin-2 with the molecular formula C690H1115N177O202S6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier M89N0Q7EQR, more generally known as aldesleukin. European Medicines Agency schedules aldesleukin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05303MIG. The term ALDESLEUKIN is an International Non-Proprietary Name or INN. see WHO INN reference publication, Volume 5, no. 3 1991, list 31. Most nations schedule aldesleukin under HS 35040000 and SITC 59225. As of Q4 2014, ALDESLEUKIN remains the US FDA Preferred Term for this commodity. Aldesleukin bears US NLM identifiers UMLS ID C0218986 and NCI Concept Code C1498. SMILES: NONE.

How AGI delivers it

Four ways AGI delivers for Aldesleukin

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Aldesleukin, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Aldesleukin, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Aldesleukin connects

measured by

  • Bacterial Endotoxin Contentmodel
  • Biological Potencymodel
  • Enzyme Specific Activitymodel
  • Protein Puritymodel